ArriVent BioPharma, Inc. Quarterly Operating Lease, Liability, Current in USD from Q4 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
ArriVent BioPharma, Inc. quarterly Operating Lease, Liability, Current history and growth rate from Q4 2023 to Q2 2024.
  • ArriVent BioPharma, Inc. Operating Lease, Liability, Current for the quarter ending June 30, 2024 was $152K.
Operating Lease, Liability, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $152K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $147K Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $140K Dec 31, 2023 10-Q 2024-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.